Imatinib mesylate therapy for polycythemia vera: Final result of a phase II study initiated in 2001

Roberto H. Nussenzveig, Jorge Cortes, Matjaz Sever, Alfonso Quintás-Cardama, Pat Ault, Taghi Manshouri, Carlos Bueso-Ramos, Josef T. Prchal, Hagop Kantarjian, Srdan Verstovsek

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib mesylate therapy for polycythemia vera: Final result of a phase II study initiated in 2001'. Together they form a unique fingerprint.

Medicine & Life Sciences